QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)

GoodRx (GDRX) Earnings Date, Estimates & Call Transcripts

$5.99
+0.19 (+3.28%)
(As of 11/30/2023 ET)
Compare
Today's Range
$5.64
▼
$6.10
50-Day Range
$4.44
▼
$5.99
52-Week Range
$4.14
▼
$9.37
Volume
3.08 million shs
Average Volume
1.59 million shs
Market Capitalization
$2.43 billion
P/E Ratio
149.79
Dividend Yield
N/A
Price Target
$7.97
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Feb. 27Estimated
Actual EPS
(Nov. 9)
$0.06
Consensus EPS
(Nov. 9)
$0.06
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

GDRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GDRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

GoodRx Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20233$0.01$0.01$0.01 
Q2 20232$0.02$0.05$0.04 
Q3 20231$0.06$0.06$0.06 
Q4 20232$0.00$0.09$0.05 
FY 20238$0.09$0.21 $0.15

GDRX Earnings Date and Information

GoodRx last released its earnings results on November 9th, 2023. The reported $0.06 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.06. The company had revenue of $180 million for the quarter, compared to the consensus estimate of $188.52 million. Its revenue was down 3.9% compared to the same quarter last year. GoodRx has generated $0.04 earnings per share over the last year ($0.04 diluted earnings per share) and currently has a price-to-earnings ratio of 149.8. Earnings for GoodRx are expected to grow by 37.50% in the coming year, from $0.08 to $0.11 per share. GoodRx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 27th, 2024 based off prior year's report dates.

GoodRx Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/27/2024
Estimated)		------- 
11/9/2023Q3 2023$0.06$0.06-$0.09$188.52 million$180.00 million    
8/9/2023Q2 2023$0.01$0.02+$0.01($0.10)$186.90 million$189.68 million
5/10/2023Q1 2023$0.01$0.01-$0.03$181.87 million$183.99 million
2/28/2023Q4 2022($0.01)$0.01+$0.02$0.02$178.17 million$184.11 million
8/8/2022Q2 2022($0.02)$0.02+$0.04$0.04$184.71 million$191.80 million    
5/9/2022Q1 2022$0.02$0.03+$0.01$0.03$200.61 million$203.30 million    
2/28/2022Q4 2021$0.03$0.01($0.02)$0.12$217.51 million$213.30 million    
11/10/2021Q3 2021$0.01$0.09+$0.08$0.02$196.08 million$195.10 million    
8/12/2021Q2 2021$0.01$0.08+$0.07($0.07)$174.15 million$176.64 million    
5/13/2021Q1 2021$0.07$0.07-($0.02)$160.61 million$160.40 million  
3/11/2021Q4 2020$0.06$0.08+$0.02($0.46)$148.01 million$153.50 million  












GoodRx Earnings - Frequently Asked Questions

When is GoodRx's earnings date?

GoodRx has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 27th, 2024 based off last year's report dates. Learn more on GDRX's earnings history.

Did GoodRx beat their earnings estimates last quarter?

In the previous quarter, GoodRx (NASDAQ:GDRX) reported $0.06 earnings per share (EPS) to hit the analysts' consensus estimate of $0.06. Learn more on analysts' earnings estimate vs. GDRX's actual earnings.

How can I listen to GoodRx's earnings conference call?

The conference call for GoodRx's latest earnings report can be listened to online. Listen to Conference Call

How can I read GoodRx's conference call transcript?

The conference call transcript for GoodRx's latest earnings report can be read online. Read Transcript

How much revenue does GoodRx generate each year?

GoodRx (NASDAQ:GDRX) has a recorded annual revenue of $766.55 million.

How much profit does GoodRx generate each year?

GoodRx (NASDAQ:GDRX) has a recorded net income of -$32.83 million. GDRX has generated $0.04 earnings per share over the last four quarters.

What is GoodRx's price-to-earnings ratio?

GoodRx (NASDAQ:GDRX) has a trailing price-to-earnings ratio of 149.79 and a forward price-to-earnings ratio of 74.88. The price/earnings-to-growth ratio is 5.98.

What is GoodRx's EPS forecast for next year?

GoodRx's earnings are expected to grow from $0.08 per share to $0.11 per share in the next year, which is a 37.50% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:GDRX) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -